MM&M first wrote about health medias COVID-19 coverage several thousand news cycles ago on February 3, to be precise. That story concluded with the following paragraph:
So it will continue to fall on health media to alternately inform, educate, soothe and de-escalate. We really need to keep thinking through how we do our jobs in an environment, like this one, where there can be misinformation. If I talk about bat soup, versus be sure to wash your hands, whats going to get more traffic? We need to do more to elevate credible information, even if it sometimes is boring.
That last quote, from WebMD chief medical officer Dr. John Whyte, feels prescient with the benefit of hindsight. Sporadic bursts of overcaution notwithstanding, health media publications and commentators embraced their elevation mission. Drowning out the deniers and grifters wasnt always easy, but nearly every health media organization attacked the task with insight and empathy. In doing so, they elevated the level of understanding and, in all likelihood, prevented people from getting sick, or sicker.
For an insider view of the continuing coverage of COVID-19, we asked leaders from a range of media-adjacent organizations to weigh in on social media follows, coverage blind spots and more. The MM&M media panel included: Jack Barrette, CEO and founder of Wego Health; Amy Conway, editor-in-chief of Health; Alexandra Gilson, director, social media at CMI/Compas; Richelle Horn, senior director, marketing at Wego Health; Craig Mait, president and chief revenue officer of Mesmerize; Andrea Palmer, president of Publicis Health Media; Georgette Pascale, founder and CEO of Pascale Communications; Dr. Judith Simmons, managing director of healthcare at Gather and founder of Lion Head Advisors; Cynthia Spitalny, senior director, integrated marketing at Outcome Health; and Whyte. Responses have been lightly edited for length and clarity.
Simmons: Good curation has been key. COVID updates at The New York Times, Johns Hopkins University of Medicine, STAT, Nature Briefing, Science, The COVID Tracking Project, The New England Journal of Medicine, Kaiser Health News and the CDC have kept up with the rapid pace of important information. Current and former officials such as Dr. Anthony Fauci, Dr. Tom Frieden and Andy Slavitt are experienced and valued voices.
Palmer: Times Up Healthcare (@timesuphc) on Twitter. Only 20% of the decision-makers in healthcare are women, which was an issue before the pandemic and will continue to be an issue if we dont advocate in this space. From a media standpoint, its been fascinating to see how brands are embracing platforms such as TikTok to spread helpful messaging, from P&Gs use of influencers to drive the #DistanceDance phenomenon to fitness and athletic companies creating at-home workout challenges.
Whyte: I focus on Twitter, because I find Instagram doesnt provide the ability to have as much dialogue. @GilBashe curates interesting scientific and policy-type articles. @JeromeAdams, the Surgeon Generals personal account, provides a personal perspective as well as succinct advice on managing the pandemic. @DrJenCaudle is an African-American physician who shares very practical advice.
Conway: On Twitter, Angela Rasmussen (@angie_rasmussen) is a Columbia virologist who shares and demystifies the latest news on COVID-19, calls out others for disinformation and promotes diversity and inclusion and manages to do it all with a dose of humor. Craig Spencer (@Craig_A_Spencer) an ER doctor and Director of Global Health at NewYork-Presbyterian/Columbia University Medical Center, has shared what it was like to be on the front lines back in March and if youre looking for guidance on masks, read his A Soliloquy on Masks. Leah Douglas (@leahjdouglas), a reporter for the Food & Environment Reporting Network, has been mapping COVID-19 outbreaks in the food system. The coverage is impressive, fascinating and terrifying.
Pascale: On Instagram, @humansofny and @wetheurban give a realistic approach to who [are] and what is really being affected.
Gilson: Governor Andrew Cuomo has been a voice of authority in this new normal, with New Yorkers being on the frontlines battling the pandemic in its early stages.
Spitalny: With multiple family members and friends working in healthcare, I am a big champion of frontline essential workers. Mask Match, a nonprofit that helps people with spare masks send them directly to healthcare workers on the front lines or donate to replenish their PPE, was something important to elevate.
Mait: We have relied on the CDC to track cases in the U.S. and for information to protect ourselves and our communities. We have also become more active on LinkedIn than ever before, seeking out leaders of similar-sized organizations to ours to see how they are responding to and dealing with the situation.
Barrette: One of my favorites on Facebook is frontline nurse and immunocompromised patient leader MarlaJan Wexler, who cuts through the politics and BS as only a nurse can do.
Whyte: Laurie McGinley at the Washington Post always provides good analysis of important issues. Shes not trying to get clicks. STAT is terrific for a daily morning update. And living in the Washington, D.C. area, I find Bob Cusack and his team at The Hill helps me understand everything happening in DC that may impact me. Its succinct and timely.
Spitalny: It has been interesting to see how mainstream journalists have been covering the innovative ways companies have addressed their business challenges during the pandemic. I have also been listening to a lot more news through podcasts, like NPRs up first and NY Times The Daily. They help prepare me for the day and keep me apprised of topics that may become important to what we message and pursue as an organization.
Palmer: COVID has shown us just how important it is to create content with a consciencecontent that works in service to the people who consume it. Lets elevate voices in the media who are dedicated to truth and facts, like Pien Huang from the Science Desk at NPR. Since the start of the outbreak, she has consistently shared thought-provoking pieces that aim to educate readers.
Conway: Olga Khazns articles for The Atlantic are engrossing and surprising, answering questions you might not even have thought to ask: Why did it take so long for therapists to start seeing clients remotely? Why does Americas sick leave policy work against its workers? Is a socially distanced pool still fun? STATs no-nonsense news reporting by Sharon Begley, Helen Branswell and Andrew Joseph goes deep into the science of COVID-19 but is always readable, engaging and enlightening.
Barrette: Overall, traditional media has pounded us with the latest hours sound bites from experts who themselves are learning real time about this disease. The result is confusion, fear, complacency and desensitized consumers
Gilson: More important than individual voices has been the collective conversation on COVID, stemming from patients and HCPs trying to navigate chronic diseases and cancer which did not let up despite the pandemic monopolizing health conversations. Those patients and their doctors are still in need of critical information, now more than ever, to keep up to date on treatments and recovery in a post-COVID world. Individual voices such as Governor Cuomo and Dr. Fauci will continue to be important in the evolving climate, but Pharma should continue to pay attention to the masses in understanding trends and sentiment within healthcare.
Pascale: Local papers and online sources are covering the news that is real and relevant to you. Sometimes its most helpful to track how things are influencing you locally, in your own backyard.
Simmons: The New York Times has stood out in providing local, national, and global views, reporting on the science, and publishing beautiful data visualizations that have helped make information clear for readers.
Mait: Unfortunately, many of us are avoiding mainstream media and news cable channels as they appear to be adding to the problem by politicizing COVID-19. Weve relied on Andrew Cuomo and Bill de Blasios daily press briefings on TV for updates on COVID-19s progress in New York. We try to listen to the medical professionals giving proper information, like the CDC, Dr. Anthony Fauci and Dr. Sanjay Gupta.
Spitalny: I am most impressed by 17-year-old Avi Schiffmann, the high school web developer who had the foresight to begin tracking COVID-19 in December when it wasnt really a news topic in the United States. His website demonstrates that ingenuity and talent can come from anywhere. Although he was offered up to $8 million from sponsors and has had numerous job offers, he declined all of it; he is adamant about protecting the integrity of the data and the site.
Simmons: Dr. Craig Smith, chair of the Department of Surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center, started writing a series of daily letters that spanned a 50,000-foot overview to the ground level of his hospital. He shared important information with perspective, warmth, context and occasionally poetry. Each letter was a realistic and human assessment of the moment and collectively they have become a narrative of the pandemic.
Palmer: NPRs What Do Coronavirus Racial Disparities Look Like State By State? should be required reading. Its thorough and outlines through visuals and statistics how and why people of color are so disproportionately affected by COVID-19. We need to put this new data into action, creating points of connection and communication where they are missing or ineffective. Moving America in a healthy direction will be about more than combatting the virus effectively; itll be about advancing our society justly and inclusively.
Conway: Some Coronavirus Guidelines, a New Yorker piece by John Kenney published in March, offers helpful guidelines on how to handle the Coronavirus crisisbeginning with the simple dont panic and wash your hands and progressing to the end of the world. Its funny because it pokes fun at the very real escalation of thoughts and fears we were having at the time (and still are!).
Whyte: The reporting in March around the growing mental health epidemic was prescient. I think some people thought it was just anxiety and would go away. But we are seeing how the pandemic is exacerbating mental health issues in those persons already diagnosed, as well as creating new mental health problems in people who never exhibited problems. I give credit to Arianna Huffington and her Thrive platform, which has been sounding the alarm bell from the beginning. The medical community has only recently come around to recognizing the problem.
Spitalny: The personal impact that this pandemic has taken on HCPs has felt overlooked. My husband is a physicians assistant and works at a major hospital, so seeing his day-to-day activity and knowing that other HCPs are probably going through something similar (burnout, cut wages for longer hours, etc.) suggest there are stories that needed to be told that were grittier than just the headline.
Whyte: We dont have an adequate explanation of the data. We report the number of cases and deaths, but we dont focus enough on local infection rates and what they mean. Early on, many cases occurred in clusters in certain counties. That was relevant to know when we talked about containment. We also didnt acknowledge the uncertainty of data, that we were learning as we went along. So we made different recommendations at different times relating to masks and antibody testing. That caused confusion and eroded trust.
Mait: During the last few months, there has been a lack of leadership from the federal government, a lack of a centralized voice with clear messaging and, of course, a lack of scientific data given the novelty of the disease. This disease is something that so clearly should not be politicized, yet it has been. What we need is a real task force with a centralized voice that everyone has access to and that is not politicized. Coverage should focus on the top doctors and what they are doing and saying about COVID-19 and the reasons why.
Simmons: The unprecedented breadth of achievements in six months related to this virus and pandemic. COVID-19 is a totally new disease and when I look back on what has been accomplished in basic science, therapeutics, clinical management, vaccine development, transmission and adjustments in how people live and work in just months its amazing. It matters because we need to use the growing bank of facts and science that we have learned to guide us as we move ahead. We know a lot more now.
Horn: Having had cancer and working so closely with patient leaders, I would like to see more coverage on how people living with chronic health conditions (immunocompromised, genetic disorders, metabolic disorders) should safely, if at all, re-enter society as things begin to open up.
Pascale: People have mistakenly thought this was going to be over by now. We need to continue to put emphasis on what we are doing as we move forward. For example, with my sons basketball camp canceled, we made do by involving him with a mini-camp in the neighborhood. These kinds of things are important to talk about, as they show how people are functioning during this time. Hyperlocal pieces can be helpful, witty and smart, and get people to a better place of understanding.
Conway: The reporting is starting to catch up, but it took a while before there was substantial coverage about how discrimination and disparity play into the pandemic. Because of long-standing inequities, African-Americans, Hispanics and Latinos and American Indians/Alaskan Natives are at increased risk for getting or becoming seriously ill with COVID-19. The LGBTQ+ community already faces discrimination when seeking healthcare and may avoid getting care. Socioeconomic disparity means that children without computers or reliable Wi-Fi are not able to learn online. Workers without paid sick leave or other benefits may put themselves or others into vulnerable situations. The list goes on.
Palmer: We need to make sure that science-based solutions are not being politicized in the news. With the rise of Black Lives Matter, we are now more aware of the social determinants that have led to disproportionate COVID-19 cases in the Black community but we havent heard enough about solutions. Black Americans are 3.5 times more likely to die of COVID-19 than White Americans. That statistic should send shock waves through everyone, and inspire wide-scale behavior change. If individuals arent doing it themselves, its worth asking in our industry how media and marketing can create the impetus for broader institutional change to take place.
Whyte: 1. Data needs to be presented in terms of local infection rates. Everyone isnt a NYC or small town in Wyoming. You need to put the data in context. 2. Stop all the talk about the vaccine, because its just not realistic. Lets have a real discussion around risk and help people understand how to live with the virus. 3. Acknowledge the role of innovation. Despite some problems with testing and mixed results from therapeutics, we had nothing five months ago. The perfect cannot be the enemy of the good.
Simmons: We havent communicated a clear understanding of how the virus is transmitted, how pandemics grow and how one persons actions may affect others. Mask wearing has become politicized, rather than normalized, and that must change. Weve got to keep refreshing peoples knowledge and presenting essential information in all ways across all platforms. This virus is not going away and we will have to adapt to it.
Conway: 1. The importance of improving diversity in the fields of science and medical care. In 2018, just 5% of active doctors in the United States identified as Black or African-American, according to the Association of American Medical Colleges. According to the American Psychological Association and American Psychiatric Association, just 4% of psychologists in the U.S. and 2% of psychiatrists are Black. Having different viewpoints and voices can improve care for all. 2. What are the long-term ramifications for children in terms of socialization, education and overall health and well-being? What services have special-needs children been gettingor more importantly, not gettingduring the pandemic?
Barrette: 1. Share concrete steps that every consumer can take, and specifically how those steps will lessen the suffering caused by the virus *in their area*. For example, if 80% of Bostonians wore masks starting now, you could watch the Red Sox in August. If its just 50%, the season is canceled. 2. Check the facts before publishing anything. If theyre wrong, either dont put them out or correct them. 3. Share more stories of how [US geography here] truly flattened the curve and back it up with data.
Spitalny: Id like to see coverage of how content providers are creating compelling, unbiased information about the benefits of wearing a mask. Id also like to see a full 360-degree look at whats happening in healthcare beyond the explosion of telehealth. Id like to see journalists tackle touchy topics like, for example, if hospitals are losing money because of electives being pushed or on the personal impact of the coronavirus crisis on HCPs in terms of mental health and loan burden. Are these crises within a crisis?
Pascale: 1. Focusing on the positives a bit more would be nice. There has been some good news that hasnt received enough recognition. 2. Reiterating that we still need to be responsible. We need to find a balance in coverage about continuing to take precautions, and how to do so. Repetition builds retention! 3. Collaborating and working together to make things happen quicker, especially scientifically. With more people sharing data when developing drugs, the endpoint can be sped up safely and effectively.
Horn: I would like to see more of an emphasis on preventative care. What are the effects of skipping or delaying appointments, or discontinuing medications? As someone who had her thyroid cancer detected during a normal well visit, I want the media to encourage people to continue to seek care during this time.
Palmer: Talk about a moving target. A little while ago, we were excited about gradual reopening and outdoor dining. By late June, we were seeing around 40,000 new cases a day, with Dr. Fauci warning the sum could rise to 100,000 new cases a day. That said, the media needs to continue focusing on prevention and caution. When this started, we saw a lot of coverage around quick fixes for our stress levels and overall quarantine wellness, such as virtual fitness classes. Now, we know we are in this for the long run, and people need endurance. They need long-term solutions to the mental health challenges were mired in. Coming off COVID-19, we need the media to look at mental health with fresh eyes and future-facing insights.
From the August 01, 2020 Issue of MM&M - Medical Marketing and Media
- Gene experts claim they identified human genes that can protect against Covid-19 - CNBC - November 23rd, 2020
- Genome Medical Reaches 90 Million Covered Lives in US - PRNewswire - November 23rd, 2020
- Sarepta Therapeutics Named One of The Boston Globe's Top Places to Work 2020 - GlobeNewswire - November 23rd, 2020
- New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer Patients - PRNewswire - November 23rd, 2020
- Baylor Genetics Launches Combination Test for COVID-19 and Influenza A and B; Multi-Panel Test Seeks to Address Dilemma of "Overlapping symptoms... - November 23rd, 2020
- CHOP Researchers Reverse Severe Lymphatic Disorder in Patient with Noonan Syndrome by Targeting Genetic Pathway - BioSpace - November 23rd, 2020
- Myriad Genetics Announces Global Expansion of Myriad myChoice Tumor Testing in Europe and China - GlobeNewswire - November 23rd, 2020
- Epigenetics and pulmonary diseases in the horizon of precision medicine: a review - DocWire News - November 23rd, 2020
- Four years after landing in US, graduating ISU senior is on his way to medical school - Iowa State University News Service - November 23rd, 2020
- Lethal brain infections in mice thwarted by decoy molecule - Washington University School of Medicine in St. Louis - November 23rd, 2020
- Reducing barriers to mainstream gene therapy - BioPharma-Reporter.com - September 4th, 2020
- Mapping Genetic Diversity of Lung Tumors Over Time May Lead to More Effective Therapies - UCSF News Services - September 4th, 2020
- Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer - PRNewswire - September 4th, 2020
- Global Prime Editing Market to Witness Heightened Growth During the Period 2020 2030 - The Daily Chronicle - September 4th, 2020
- Liquid biopsies to disrupt the oncology testing market - Medical Device Network - September 4th, 2020
- Global RNA-interference (RNAi) Market Growth, Trends and Forecasts to 2025: Focus on Key Players Alnylam Pharmaceuticals, Arrowhead, Quark... - September 4th, 2020
- Yale researchers find a cause and possible treatment for Fragile X - Yale News - September 4th, 2020
- 'Coming into their own': FDA approval of liquid biopsy tests puts early, less invasive cancer detection in broader reach - USA TODAY - September 4th, 2020
- Fusion Genes Associated With More Aggressive Papillary Thyroid Cancer in Pediatric Patients - Targeted Oncology - September 4th, 2020
- Existing Class of Drugs May Improve Neurological Function in Patients with Rare, Aggressive Genetic Disorder - Newswise - September 4th, 2020
- Genomic analysis reveals insights on virulent, emerging foodborne pathogen - UB Now: News and views for UB faculty and staff - University at Buffalo... - September 4th, 2020
- Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors - 2 Minute Medicine - September 4th, 2020
- Health history platform launches to trace genetic conditions | Digital Healthcare - Healthcare Global - Healthcare News, Magazine and Website - September 4th, 2020
- New HIV Gene Therapy, CAR-T Treatments Could be on the Horizon for Patients - BioSpace - September 4th, 2020
- Cell Suicide Gene Further Linked to Immunotherapy Response - Technology Networks - September 2nd, 2020
- Genetic mutations may be linked to infertility, early menopause - Washington University School of Medicine in St. Louis - September 2nd, 2020
- How to use precision medicine to personalise COVID-19 treatment according to the patient's genes - Down To Earth Magazine - September 2nd, 2020
- UCT professors research offers hope of treatment for sickle cell anaemia - Daily Maverick - September 2nd, 2020
- Association of recent stressful life events with mental and physical health in the context of genomic and exposomic liability for schizophrenia - 2... - September 2nd, 2020
- Finding order in the chaos of cancer mutations - Drug Target Review - September 2nd, 2020
- Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency in Newly Diagnosed Infants -... - September 2nd, 2020
- Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine - GlobeNewswire - September 2nd, 2020
- Department of Genetic Medicine | Johns Hopkins Medicine - August 10th, 2020
- Genetic Medicine | Internal Medicine | Michigan Medicine ... - August 10th, 2020
- Genetic Medicine | Department of Medicine - August 10th, 2020
- Genomics and Medicine - Genome.gov - August 10th, 2020
- New Approach to Treating Osteoarthritis Advances | NYU Langone News - NYU Langone Health - August 10th, 2020
- Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates - Business Wire - August 10th, 2020
- Here's Why Shares of Editas Medicine and Beam Therapeutics Are Soaring Today - Motley Fool - August 10th, 2020
- Grant will fund study into COVID outcome disparities in NYC - Cornell Chronicle - August 10th, 2020
- A versatile genetic control system in mammalian cells and mice responsive to clinically licensed sodium ferulate - Science Advances - August 10th, 2020
- Spark Therapeutics Deepens Drug Development Expertise in Hematology and Rare Disease with Appointment of Gallia G. Levy, MD, Ph.D., as Chief Medical... - August 10th, 2020
- Chromosomal Rearrangements Associated with Chemotherapeutic Drug Resistance | McDonnell Boehnen Hulbert & Berghoff LLP - JD Supra - August 10th, 2020
- Jae Jung, Ph.D., Appointed as Chair of Cleveland Clinic Lerner Research Institute's Department of Cancer Biology - Health Essentials from Cleveland... - August 10th, 2020
- The UK and TCELS to jointly support COVID-19 research in Thailand - GOV.UK - August 10th, 2020
- Akouos Announces Expansion of Executive Team and Board of Directors - BioSpace - August 10th, 2020
- Medical and neurobehavioural phenotypes in male and female carriers of Xp22.31 duplications in the UK Biobank. - Physician's Weekly - August 10th, 2020
- Coronavirus vaccine breakthrough: New generation cure that stops virus developed - Express - August 10th, 2020
- Global Cell and Gene Therapy Market, Forecast to 2025 by Product, Disease, End-user and Region - COVID-19 Updated - PRNewswire - August 10th, 2020
- Not Everyone Needs 8 Hours of Sleep, New Research Reveals | Time - TIME - August 10th, 2020
- Lindsey Criswell Named Director of National Institute of Arthritis and Musculoskeletal and Skin Diseases - UCSF News Services - August 10th, 2020
- Pinpointing The Cells That Keep The Bodys Master Circadian Clock Ticking - Newswise - August 10th, 2020
- Kazia Therapeutics hits A$1 on grant of Rare Pediatric Disease Designation to paxalisib for DIPG - Proactive Investors USA & Canada - August 10th, 2020
- Treatment Considerations for Prostate Cancer Progressing After Combination Therapy for mCSPC - UroToday - August 10th, 2020
- Edited Transcript of PSNL.OQ earnings conference call or presentation 6-Aug-20 9:00pm GMT - Yahoo Finance - August 10th, 2020
- Ovid and Angelini partner on treating Angelman syndrome in Europe - Pharmaceutical Technology - August 10th, 2020
- Doctoral Student/Research Assistant in Mitochondrial Biology and Signalling job with UNIVERSITY OF HELSINKI | 218596 - Times Higher Education (THE) - August 10th, 2020
- Simpler COVID-19 test could provide results in hours from saliva - University of Wisconsin-Madison - August 10th, 2020
- This company has a better version of a simpler, faster Covid-19 test - STAT - August 7th, 2020
- Mental Notes: Music Cognition Lab is dedicated to the scientific study of how music affects the brain and behavior - Vanderbilt University News - August 6th, 2020
- Nasha Fitter Elected to Board of Directors of the ACMG Foundation for Genetic and Genomic Medicine - PRNewswire - August 5th, 2020
- HDAC6 Can Control Tumor Growth and Halt Metastasis in Triple-Negative Breast Cancer - Newswise - August 5th, 2020
- Will programming a cell ever be as easy as programming an app? - SynBioBeta - August 5th, 2020
- Penn Researchers Identify New Genetic Cause of a Form of Inherited Neuropathy - Newswise - August 5th, 2020
- Genetic Variant in Persons of African Descent Linked with Stroke: Analysis - DocWire News - August 5th, 2020
- Invitae Reports $46.2 Million in Revenue Driven by More Than 120000 Samples Accessioned in the Second Quarter of 2020 - Monterey County Weekly - August 5th, 2020
- Noel R. Rose, widely regarded as the father of autoimmune disease research, dies at 92 - The Hub at Johns Hopkins - August 5th, 2020
- Atsena Therapeutics acquires exclusive rights to Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis - GlobeNewswire - August 5th, 2020
- Seragon Announces GenomeScore, the First AI Platform to Measure Rate of Aging and Physiological Changes - PRNewswire - August 5th, 2020
- Vaccine 'durability': COVID-19 immunizations coming soon but will they last? - Genetic Literacy Project - August 5th, 2020
- Aerpio Pharmaceuticals, Inc. Announces a Second Clinical Trial with Funding from MTEC to Evaluate Razuprotafib for the Prevention and Treatment of... - August 5th, 2020
- Stoke Therapeutics to Present at Upcoming Investor Conferences in August - Business Wire - August 4th, 2020
- The global cell and gene therapy market by revenue is expected to grow at a CAGR of over 30.90% during the period 20192025 - GlobeNewswire - August 4th, 2020
- Cochlear implant uses LEDs to tackle hearing loss - Optics.org - August 4th, 2020
- Rozlytrek, Roche's first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with... - August 4th, 2020
- Alnylam Pharmaceuticals : Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis -... - August 4th, 2020
- 'The younger the child, the likelier to find causative gene of infant epilepsy' - Korea Biomedical Review - Korea Biomedical Review - August 3rd, 2020
- Known genes associated with male infertility doubled - BioNews - August 3rd, 2020
- Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis (NASH) - Business... - August 3rd, 2020
- Cancer drug is first therapy to emerge from 23andMe-GSK deal - STAT - STAT - August 3rd, 2020